These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26219392)

  • 1. Chalcones as Promising Lead Compounds on Cancer Therapy.
    León-González AJ; Acero N; Muñoz-Mingarro D; Navarro I; Martín-Cordero C
    Curr Med Chem; 2015; 22(30):3407-25. PubMed ID: 26219392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
    Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
    Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
    Srinivasan B; Johnson TE; Lad R; Xing C
    J Med Chem; 2009 Nov; 52(22):7228-35. PubMed ID: 19883086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in chalcones with anticancer activities.
    Karthikeyan C; Moorthy NS; Ramasamy S; Vanam U; Manivannan E; Karunagaran D; Trivedi P
    Recent Pat Anticancer Drug Discov; 2015; 10(1):97-115. PubMed ID: 25138130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Activity of Natural and Synthetic Chalcones.
    Constantinescu T; Lungu CN
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
    WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
    Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
    Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
    Gao F; Huang G; Xiao J
    Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chalcone Derivatives: Role in Anticancer Therapy.
    Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterocyclic chalcone analogues as potential anticancer agents.
    Sharma V; Kumar V; Kumar P
    Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Active Heterocyclic Chalcones: Recent Developments.
    Dandawate P; Ahmed K; Padhye S; Ahmad A; Biersack B
    Anticancer Agents Med Chem; 2021; 21(5):558-566. PubMed ID: 32628595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivities of chalcones.
    Dimmock JR; Elias DW; Beazely MA; Kandepu NM
    Curr Med Chem; 1999 Dec; 6(12):1125-49. PubMed ID: 10519918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
    Atukuri D; S V; R S; L V; R P; M M R
    Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect.
    Vogel S; Barbic M; Jürgenliemk G; Heilmann J
    Eur J Med Chem; 2010 Jun; 45(6):2206-13. PubMed ID: 20153559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
    Loa J; Chow P; Zhang K
    Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
    Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
    Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
    Gibson MZ; Nguyen MA; Zingales SK
    Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells.
    Kim SY; Lee IS; Moon A
    Chem Biol Interact; 2013 May; 203(3):565-72. PubMed ID: 23562496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents.
    Rioux B; Pouget C; Fidanzi-Dugas C; Gamond A; Laurent A; Semaan J; Pinon A; Champavier Y; Léger DY; Liagre B; Duroux JL; Fagnère C; Sol V
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4354-4357. PubMed ID: 28838697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
    Kupcewicz B; Jarzęcki AA; Małecka M; Krajewska U; Rozalski M
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4260-5. PubMed ID: 25091929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.